| scholarly article | Q13442814 |
| P50 | author | Jordi B Torrelles | Q89438944 |
| P2093 | author name string | Varun Dwivedi | |
| Gourapura J Renukaradhya | |||
| Cordelia Manickam | |||
| Kang Ouyang | |||
| Basavaraj Binjawadagi | |||
| P2860 | cites work | Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. | Q30374900 |
| CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naïve and antigen-primed T cells | Q33359892 | ||
| Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength. | Q34025399 | ||
| Type 1/Type 2 immunity in infectious diseases | Q34105379 | ||
| Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses | Q34115645 | ||
| Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. | Q34233101 | ||
| Porcine reproductive and respiratory syndrome virus-induced immunosuppression exacerbates the inflammatory response to porcine respiratory coronavirus in pigs | Q34259886 | ||
| Mycobacterium tuberculosis whole cell lysate enhances proliferation of CD8 positive lymphocytes and nitric oxide secretion in the lungs of live porcine respiratory and reproductive syndrome virus vaccinated pigs | Q34269264 | ||
| Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone | Q34328895 | ||
| Biodegradable nanoparticle-entrapped vaccine induces cross-protective immune response against a virulent heterologous respiratory viral infection in pigs | Q34512592 | ||
| Isolation and Properties of a Macromolecular, Water-Soluble, Immuno-Adjuvant Fraction from the Cell Wall of Mycobacterium smegmatis | Q34698893 | ||
| Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection | Q35039282 | ||
| Biodegradable nanoparticles for drug and gene delivery to cells and tissue | Q35082117 | ||
| The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods | Q35122248 | ||
| SYMPOSIUM ON RELATIONSHIP OF STRUCTURE OF MICROORGANISMS TO THEIR IMMUNOLOGICAL PROPERTIES. II. HOST-REACTIVE PROPERTIES OF CELL WALLS AND PROTOPLASM FROM MYCOBACTERIA | Q35416935 | ||
| Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production | Q35802766 | ||
| Role of neutralizing antibodies in PRRSV protective immunity | Q35928806 | ||
| PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses | Q35972569 | ||
| Nanotechnology for the biologist | Q36143597 | ||
| Chronological immunohistochemical detection and localization of porcine reproductive and respiratory syndrome virus in gnotobiotic pigs | Q45766971 | ||
| Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype | Q47097020 | ||
| Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. | Q51372135 | ||
| Restriction fragment length polymorphism of porcine reproductive and respiratory syndrome viruses recovered from Ontario farms, 1998-2000. | Q51708743 | ||
| PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. | Q51855407 | ||
| CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo. | Q53229710 | ||
| Cellular variables in bronchoalveolar lavage fluids (BALF) in selected healthy pigs. | Q53704516 | ||
| Mucosal immune response to poliovirus vaccines in childhood | Q71407437 | ||
| Measurement of immunoglobulin G, A and M concentrations in boar seminal plasma | Q73330329 | ||
| The influence of components of M. tuberculosis and other Mycobacteria upon antibody production to ovalbumin | Q74818901 | ||
| Influence of the surfactant concentration on the body distribution of nanoparticles | Q77794198 | ||
| Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus | Q36315144 | ||
| Antigen-specific B-cell responses to porcine reproductive and respiratory syndrome virus infection | Q36423967 | ||
| Debugging how bacteria manipulate the immune response. | Q36739044 | ||
| Polymeric nano- and microparticle technologies for oral gene delivery | Q36815912 | ||
| Role of nanotechnology in pharmaceutical product development. | Q36905823 | ||
| Is intranasal vaccination a feasible solution for tuberculosis? | Q37316013 | ||
| Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology | Q37493297 | ||
| Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs | Q37537840 | ||
| Nanotechnology solutions for mucosal immunization | Q37636849 | ||
| Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers | Q37728017 | ||
| Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology. | Q37775727 | ||
| Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns | Q37800358 | ||
| Adjuvants and delivery systems in veterinary vaccinology: current state and future developments | Q37822316 | ||
| Towards tailored vaccine delivery: needs, challenges and perspectives. | Q37975885 | ||
| Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective | Q38020309 | ||
| Recent progress in mucosal vaccine development: potential and limitations | Q38029250 | ||
| Adjuvant and immunostimulating activities of water-soluble substances extracted from Mycobacterium tuberculosis (var. hominis) | Q39087971 | ||
| Porcine reproductive and respiratory syndrome virus induces pronounced immune modulatory responses at mucosal tissues in the parental vaccine strain VR2332 infected pigs | Q39274756 | ||
| The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo | Q40691486 | ||
| Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions | Q42590160 | ||
| Heterogeneity in Nsp2 of European-like porcine reproductive and respiratory syndrome viruses isolated in the United States. | Q42622170 | ||
| Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations | Q42650574 | ||
| Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies | Q43293002 | ||
| Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. | Q43756344 | ||
| Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. | Q44243477 | ||
| PLGA nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigs | Q44365260 | ||
| The assessment of antibody affinity distribution by thiocyanate elution: a simple dose-response approach. | Q44403655 | ||
| Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. | Q44469509 | ||
| Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant | Q44695132 | ||
| Vaccine manufacturing: challenges and solutions | Q44862237 | ||
| Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery | Q44985757 | ||
| Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine | Q45056726 | ||
| Intranasal delivery of an adjuvanted modified live porcine reproductive and respiratory syndrome virus vaccine reduces ROS production | Q45361497 | ||
| Intranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigs | Q45368085 | ||
| Porcine reproductive and respiratory syndrome virus subverts repertoire development by proliferation of germline-encoded B cells of all isotypes bearing hydrophobic heavy chain CDR3. | Q45397373 | ||
| Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo | Q45399315 | ||
| Effect of genotypic and biotypic differences among PRRS viruses on the serologic assessment of pigs for virus infection | Q45404561 | ||
| Porcine reproductive and respiratory syndrome virus productively infects monocyte-derived dendritic cells and compromises their antigen-presenting ability | Q45411355 | ||
| Gammadelta lymphocyte response to porcine reproductive and respiratory syndrome virus | Q45423447 | ||
| Polyclonal hypergammaglobulinemia and formation of hydrophobic immune complexes in porcine reproductive and respiratory syndrome virus-infected and uninfected pigs | Q45488617 | ||
| Detection and duration of porcine reproductive and respiratory syndrome virus in semen, serum, peripheral blood mononuclear cells, and tissues from Yorkshire, Hampshire, and Landrace boars | Q45737883 | ||
| Porcine reproductive and respiratory syndrome virus: a persistent infection | Q45761836 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanotechnology | Q11468 |
| porcine reproductive and respiratory syndrome virus | Q1760147 | ||
| porcine reproductive and respiratory syndrome | Q2275037 | ||
| P304 | page(s) | 1519-1535 | |
| P577 | publication date | 2014-03-24 | |
| P1433 | published in | International Journal of Nanomedicine | Q6051502 |
| P1476 | title | An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination | |
| P478 | volume | 9 |
| Q37623519 | Assessment of the efficacy of two novel DNA vaccine formulations against highly pathogenic Porcine Reproductive and Respiratory Syndrome Virus |
| Q96304796 | Cloaked Viruses and Viral Factors in Cutting Edge Exosome-Based Therapies |
| Q36700988 | Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study. |
| Q47137438 | Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens |
| Q30387075 | Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs. |
| Q36424830 | Evaluation of humoral immune status in porcine epidemic diarrhea virus (PEDV) infected sows under field conditions |
| Q30234558 | Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine |
| Q40046407 | Improved Vaccine against PRRSV: Current Progress and Future Perspective |
| Q39487800 | Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets. |
| Q64230355 | Key Gaps in the Knowledge of the Porcine Respiratory Reproductive Syndrome Virus (PRRSV) |
| Q58698634 | Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs |
| Q38801171 | Mutations in a Highly Conserved Motif of nsp1β Protein Attenuate the Innate Immune Suppression Function of Porcine Reproductive and Respiratory Syndrome Virus. |
| Q55357132 | Nonstructural proteins nsp2TF and nsp2N of porcine reproductive and respiratory syndrome virus (PRRSV) play important roles in suppressing host innate immune responses. |
| Q36598433 | Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation |
| Q27321003 | Serum-derived exosomes from non-viremic animals previously exposed to the porcine respiratory and reproductive virus contain antigenic viral proteins |
| Q50031504 | Targeted Delivery of GP5 Antigen of PRRSV to M Cells Enhances the Antigen-Specific Systemic and Mucosal Immune Responses |
Search more.